PMID- 29444822 OWN - NLM STAT- MEDLINE DCOM- 20190107 LR - 20210205 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 293 IP - 14 DP - 2018 Apr 6 TI - The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones. PG - 5134-5149 LID - 10.1074/jbc.M117.813790 [doi] AB - Loss-of-function mutations of the protein kinase PERK (EIF2AK3) in humans and mice cause permanent neonatal diabetes and severe proinsulin aggregation in the endoplasmic reticulum (ER), highlighting the essential role of PERK in insulin production in pancreatic beta cells. As PERK is generally known as a translational regulator of the unfolded protein response (UPR), the underlying cause of these beta cell defects has often been attributed to derepression of proinsulin synthesis, resulting in proinsulin overload in the ER. Using high-resolution imaging and standard protein fractionation and immunological methods we have examined the PERK-dependent phenotype more closely. We found that whereas proinsulin aggregation requires new protein synthesis, global protein and proinsulin synthesis are down-regulated in PERK-inhibited cells, strongly arguing against proinsulin overproduction being the root cause of their aberrant ER phenotype. Furthermore, we show that PERK regulates proinsulin proteostasis by modulating ER chaperones, including BiP and ERp72. Transgenic overexpression of BiP and BiP knockdown (KD) both promoted proinsulin aggregation, whereas ERp72 overexpression and knockdown rescued it. These findings underscore the importance of ER chaperones working in concert to achieve control of insulin production and identify a role for PERK in maintaining a functional balance among these chaperones. CI - (c) 2018 by The American Society for Biochemistry and Molecular Biology, Inc. FAU - Sowers, Carrie R AU - Sowers CR AD - From the Department of Biology, Penn State University, University Park, Pennsylvania 16802. FAU - Wang, Rong AU - Wang R AD - From the Department of Biology, Penn State University, University Park, Pennsylvania 16802. FAU - Bourne, Rebecca A AU - Bourne RA AD - From the Department of Biology, Penn State University, University Park, Pennsylvania 16802. FAU - McGrath, Barbara C AU - McGrath BC AD - From the Department of Biology, Penn State University, University Park, Pennsylvania 16802. FAU - Hu, Jingjie AU - Hu J AD - From the Department of Biology, Penn State University, University Park, Pennsylvania 16802. FAU - Bevilacqua, Sarah C AU - Bevilacqua SC AD - From the Department of Biology, Penn State University, University Park, Pennsylvania 16802. FAU - Paton, James C AU - Paton JC AD - the Department of Molecular and Cellular Biology, Research Centre for Infectious Diseases, University of Adelaide, Adelaide 5005, Australia. FAU - Paton, Adrienne W AU - Paton AW AD - the Department of Molecular and Cellular Biology, Research Centre for Infectious Diseases, University of Adelaide, Adelaide 5005, Australia. FAU - Collardeau-Frachon, Sophie AU - Collardeau-Frachon S AUID- ORCID: 0000-0001-8604-1089 AD - the Department of Pathology, Hopital-Femme-Mere-Enfant, Hospices Civils de Lyon, Universite Claude Bernard Lyon I and CarMeN, INSERM Unit U1060, 69677 Bron, France, and. FAU - Nicolino, Marc AU - Nicolino M AUID- ORCID: 0000-0001-5395-2249 AD - the Service d'endocrinologie et de diabetologie pediatriques et maladies hereditaires du metabolisme, Hopital Femme-Mere-Enfant, Hospices Civils de Lyon, F-69677 Bron, France. FAU - Cavener, Douglas R AU - Cavener DR AUID- ORCID: 0000-0002-1558-7137 AD - From the Department of Biology, Penn State University, University Park, Pennsylvania 16802, drc9@psu.edu. LA - eng GR - R01 DK088140/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20180214 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Insulin) RN - 0 (Molecular Chaperones) RN - 9035-68-1 (Proinsulin) RN - EC 2.7.11.1 (EIF2AK3 protein, human) RN - EC 2.7.11.1 (PERK kinase) RN - EC 2.7.11.1 (eIF-2 Kinase) RN - IY9XDZ35W2 (Glucose) RN - Diabetes Mellitus, Permanent Neonatal SB - IM MH - Animals MH - Diabetes Mellitus/metabolism MH - Endoplasmic Reticulum/physiology MH - Glucose/metabolism MH - Humans MH - Insulin/metabolism MH - Insulin-Secreting Cells/metabolism MH - Mice MH - Mice, Knockout MH - Molecular Chaperones/metabolism MH - Proinsulin/genetics/*metabolism MH - Protein Biosynthesis/drug effects MH - Unfolded Protein Response/drug effects MH - eIF-2 Kinase/genetics/*metabolism PMC - PMC5892574 OTO - NOTNLM OT - BiP OT - PERK OT - beta cells OT - chaperone OT - endoplasmic reticulum (ER) OT - insulin secretion OT - intracellular trafficking OT - protein aggregation COIS- The authors declare that they have no conflicts of interest with the contents of this article EDAT- 2018/02/16 06:00 MHDA- 2019/01/08 06:00 PMCR- 2019/04/06 CRDT- 2018/02/16 06:00 PHST- 2017/08/21 00:00 [received] PHST- 2018/02/06 00:00 [revised] PHST- 2018/02/16 06:00 [pubmed] PHST- 2019/01/08 06:00 [medline] PHST- 2018/02/16 06:00 [entrez] PHST- 2019/04/06 00:00 [pmc-release] AID - S0021-9258(20)40987-1 [pii] AID - M117.813790 [pii] AID - 10.1074/jbc.M117.813790 [doi] PST - ppublish SO - J Biol Chem. 2018 Apr 6;293(14):5134-5149. doi: 10.1074/jbc.M117.813790. Epub 2018 Feb 14.